tirzepatide patent expiration date us Drug Patents containing The Heavy Price of GLP-1

At the low doses, the drug has been remarkably well tolerated

P., et al., Efficacy and Safety of a Novel Dual GIP and GLP1 Receptor Agonist Tirzepatide in Patients With Type 2 Diabetes (SURPASS1): A DoubleBlind, Randomised, Phase 3 Trial, Lancet 398, no

At DrNewMed, we recognize that your weight loss journey is unique, and our Medical Weight Loss Programs featuring Semaglutide and Tirzepatide (Mounjaro) are designed to support your individual goals

Women of childbearing age should use contraception while on tirzepatide and discontinue the medication at least 2 months before attempting conception to allow complete washout given the long half-life

Tirzepatide achieved an average weight loss of 20.2% compared to 13.7% for semaglutide

Your myBMI clinician can review your progress and work with you to find the dose that best supports your weight loss journey